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Abstract 
 
Introduction:  Intracytoplasmic  sperm  injection  (ICSI)  is  a  widely  used  adjunct  to  in  vitro 
fertilization  (IVF)  for  male-factor  infertility  when  fertilization  failure  is  suspected.  In  patients 
with borderline semen, the decision to choose either IVF or ICSI is critical because the chance of 
total fertilization failure after a conventional IVF or of performing an unnecessary ICSI procedure 
is hard to predict. 
 
Objective: The purpose of this study was to assess the value of the allocation of some eggs to 
ICSI and others to conventional insemination (Split ICSI/insemination) in IVF cycles in which 
semen parameters are subfertile. 
 
Design: It is prospective study. 
 
Materials and methods: Between August 2007 and April 2010, 190 patients had half of their 
eggs inseminated with ICSI and the other half inseminated with conventional IVF. 
 
Results:  In this study, 76.3% of patients were fertilized by both IVF and ICSI, 21.6% of patients 
were fertilized only by ICSI while 2.1% of patients were not fertilized either by IVF or ICSI. 
Fertilization rate was significantly higher in oocytes injected by ICSI (63.7%) compared to oocyte 
inseminated  by  IVF  (44.3%).  In  patients  fertilized  by  both  IVF  and  ICSI,  although  ICSI 
fertilization rate was higher (65.9%) than IVF fertilization rate (57.3%), yet there is no significant 
differences were observed. High grade embryos were significantly higher in oocytes injected by 
ICSI (75.9%) compared to oocyte inseminated by IVF (56.4%). Also, significantly more type 1 
and  2  embryos  developed  after  ICSI  compared  with  IVF  (77.3%  vs.  56.4%)  in  the  group  of 
patients with fertilization after both IVF and ICSI.  
 
Conclusion: According to our findings, implementation of ICSI in couples with mild male factor 
infertility could improve fertilization rates and decrease the risk of complete fertilization failure. 
Additionally,  split  ICSI  procedure  provides  valuable  clinical  information  about  fertilization 
potential for the couple and unnecessary use of ICSI procedure can be avoided in future cycles for 
patients who have achieved good fertilization in both IVF and ICSI. 
 
Keywords:  ICSI(Intracytoplsmic  sperm  injection)-IVF(Invitrofertlization)-OCCs(Oocyte-
cumulus complexes). 
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Introduction 
 
In  assisted  reproduction  programmes, 
decisions  concerning  the  treatment 
technique  (IVF  or  ICSI)  are  usually  made 
after the evaluation of male fertility factors, 
or taking into account the results of previous 
IVF attempts. There are no widely accepted 
criteria, so  decisions  for couples  with  male 
subfertility  (i.e.  at  least  one  sperm 
characteristic abnormal) are often empirical 
and  may  lead  to  complete  fertilization 
failure after IVF, or to the unnecessary use 
of ICSI.  
 
Threshold  values  of  sperm  parameters  for 
assisted procreation are based mainly on the 
World Health Organization standard (1999) 
and widely are used to discriminate between 
male fertility and subfertility (Pisarska1999, 
Verheyen  G  1999  &  HlagerhA2002). 
However,  the  prognostic  value  of  those 
parameters  is  questionable  (LiuDY2000, 
LiuDY2002  &  GuzickDS2001).  Mahutte 
and  Arici  (2003)  conducted  a  review  of 
different  screening  tests.  Their  conclusion 
was that more sophisticated methods such as 
sperm–zona  binding  ratios  and  zona 
pellucida–induced  acrosome  reaction  tests 
may  improve  the  ability  to  predict 
fertilization  capacity,  but  unfortunately,  no 
test  can  exclude  the  possibility  of 
fertilization failure.  
 
The majority  of  failed  fertilized  oocytes  do 
not  contain  sperm  nuclei  after  conventional 
IVF  (WallMB1996  &  Edirisingh1997) 
indicating  that  most  cases  of  fertilization 
failure relate to an inability of the sperm cell 
to  penetrate  the  oocyte.  Oocyte-related 
factors  that  might  account  for  fertilization 
failure in some cases could be defects in the 
pronuclear formation or an oocyte activation 
failure (MahutteNG2003).  
 
Intracytoplasmic sperm injection (ICSI) with 
its high fertilization and pregnancy rates has 
replaced  conventional  IVF  and  other  types 
of micromanipulation as first-line therapy in 
couples  with  severe  male  factor  infertility 
(PayneD1994,  PalermoG1993&  Van 
SteirteghemAC(1993). The high success rate 
of ICSI has led to extension of the technique 
to  other  patient  populations  for  whom 
conventional  IVF  may  be  an  option, 
including  subfertile  males  and  unexplained 
infertility  (Aboulghar1996).  However,  the 
role  of  ICSI  in  men  with  mild  sperm 
impairment  and  in  men  with  normal  sperm 
characteristics  but  low  fertilization  rates 
with  conventional  IVF  treatment  has  not 
been well established (Shai E2004). 
 
One  of  the  major  concerns  in  treating 
couples  with  moderate  sperm  impairment 
(moderate  oligo  ±  astheno  ±  teratospermia) 
is  the  wide  range  of  complete  fertilization 
failure  with  conventional  IVF  treatment, 
reported as being present in 4%–50% of the 
couples.  It  is  tempting  to  propose  ICSI  to 
those  couples  as  a  means  of  decreasing 
complete  fertilization  failure 
(VerheyenG1999,  Aboulghar1996, 
FishelS2000  &  PlachotM2002).  ICSI, 
however, is time consuming, expensive, and 
involves  unresolved  concerns  regarding  the 
short-  and  long-term  outcomes  of  the 
conceived newborns (HansenM2002). 
   
Due  to  these  conflicting  results,  several 
groups  have  suggested  that  conventional 
IVF  and  ICSI  should  be  performed  on 
sibling  oocytes  (the  IVF-ICSI  split 
procedure) in patients with male subfertility 
to  reduce  the  risk  of  complete  fertilization 
failure  (Pisarska1999,  VerheyenG1999, 
VanSteireghem1993,PlachotM2002, 
CalderonG1995&Vander  Westerlaken2006); 
others  have  suggested  this  technique  in 
couples  with  unexplained  infertility 
(HershlagA2002)  or  with  previous 
unexplained  fertilization  failure  (Fishel 
S2000,  Van  der  Westerlaken2006  & 
Benadiva1999). 
We  therefore  conducted  a  study  in  which 
half  the  oocytes  from  couples  with  mild 
male factor infertility (mild oligo ± astheno 
±  teratospermia)  were  inseminated  (IVF) 
and the other half microinjected (ICSI).  
The  purpose  of  the  current  study  was  to 
assess whether the performance of the IVF-Split ICSI/Insemination…. 
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ICSI split insemination method can improve 
fertilization  rates  and  reduce  the  risk  of 
fertilization  failure  in  couples  with  mild 
male factor infertility. 
   
Materials and Methods 
 
Patients: 
This  prospective  study  included  a  total  of 
190  couples  attending  the  in  vitro 
fertilization  (IVF)  program  of  IVF 
Department  (Enjab  Hospital)  between 
August 2007 and April 2010. The cases with 
subfertile semen parameters were selected to 
undergo an IVF cycle in which oocytes were 
divided  without  prejudice  between 
conventional IVF and ICSI.  
 
Mild male-factor subfertility was defined by 
the presence of at least one abnormal semen 
parameter,  i.e.,  count  of  5  -  20  ×  10
6/mL, 
motility  of  25  -  40%,  or  20%–30%  of 
spermatozoa  classed  as  morphologically 
normal  according  to  World  Health 
Organization  (1999)  criteria  and  Kruger 
strict criteria (1986 & 1988).  
 
Patients  were  included  in  this  study  on  the 
basis of previous diagnostic semen analyses 
and  when,  on  the  day  of  oocyte  retrieval, 
their semen fulfilled the above criteria again. 
Women  who  had  poor  response  (<  four 
retrieved  oocytes)  or  prior  enrolled  in  this 
study were excluded. 
   
The  study  got  approval  from  UAE  ethical 
committee  (UEC)  and  informed  consent  of 
patients was  documented before  being  included 
in the study.  
 
 
Setting:  
This  study  was  conducted  at  private 
IVF/ICSI units (Enjab Hospital for infertility 
and  Gulf  Medical  College  and  Research 
Centre, Sharjah, UAE). 
 
Stimulation protocol: 
The  women  participating  in  this  study 
followed a long GnRH agonist protocol that 
began  with  daily  S.C  injections  of  0.1  mg 
triptoreline  (Ipsen  pharma  biotech,  France) 
on Day 21 of the pre-stimulation cycle. The 
GnRH  agonist  was  continued  until  the  day 
of HCG administration. E2 levels less  than 
50  pg/mL  on  cycle  day  3  and  endometrial 
thickness  less  than  4  mm  indicated  down-
regulation.  Gonadotropin  was  administered 
daily  by  S.C  injection  of  follitropin  beta 
(Puregon;  Organon,  Netherlands)  in  a  dose 
of 200 IU/day started from the third day of 
the cycle for five days after which the level 
was  adjusted  according  to  the  associated 
ovarian  response  in  order  to  stimulate 
follicular  development.  The  resultant 
ovarian  response  was  monitored  by 
transvaginal ultrasound and serum E2 levels. 
In cases of less than three growing follicles 
on  cycle  day  14,  treatment  cycle  was 
canceled.  When  three  or  more  follicles 
reached  a  maximum  diameter  of  18  mm, 
10,000  IU  of  hCG  (Pregnyl;  Organon, 
Holland) was administered.  
 
Semen Preparation: 
Freshly  ejaculated  semen  was  allowed  to 
liquefy.  Volume  was  determined, 
concentration  and  percentage  of  motile 
spermatozoa  were  assessed  in  a  Makler 
counting  chamber,  and  the  total  number  of 
motile  spermatozoa  was  calculated.  The 
semen  sample  was  diluted  1:2  with  Sperm 
preparation  media  (Medicult;  Lucron, 
Milsbeek, the Netherlands) in a 12-mL tube 
and was processed by centrifuge (1500-2000 
r/minute  for  10  minutes).  The  supernatant 
was removed, and the sperm pellet (0.1–0.5 
mL)  was  re-suspended  in  1  mL  of  Sperm 
preparation  media  and  processed  by 
centrifuge  (1500-2000  r/minute  for  5 
minutes). The supernatant was removed, and 
the  sperm  pellet  (0.1–0.5  mL)  was  used. 
Volume,  concentration,  motility,  and  the 
total motile sperm count were re-determined 
after processing. The spermatozoa were kept 
at  37°C  in  a  CO2  incubator  until  IVF  or 
ICSI took place. 
 
Oocyte Retrieval and Preparation: 
Transvaginal oocyte retrieval was performed 
under  general  anesthesia  by  one  operator 
(A.M)  34–36  h  after  hCG  injection.  The Split ICSI/Insemination…. 
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retrieved  oocyte–cumulus  complexes 
(OCCs) were pooled and washed in HEPES-
buffered Earle’s medium and then randomly 
transferred  in  groups  of  two  to  six  OCCs 
(depending  on  the  total  number  of  OCCs 
retrieved)  to  droplets  of  25-μL  of  culture 
medium  (universal  IVF  medium;  Medicult) 
under  mineral  oil  (Sigma,  Brunswig 
Chemie,  Amsterdam,  the  Netherlands)  and 
then put into an incubator (37°C, 5% CO2). 
Before injection  or  insemination,  the  OCCs 
were  taken  out  of  the  incubator  and 
randomly  divided  for  ICSI  or  IVF 
insemination.  
 
The OCCs that were assigned to ICSI were 
denuded  of  their  surrounding  cumulus  cells 
both enzymatically and mechanically at 0-2 
hours  after  retrieval.  The  maturation  stage 
was  checked,  and  the  oocytes  that  had 
extruded  a  polar  body  were  selected  for 
injection.  After  injection,  the  oocytes  were 
transferred  to  25-μL  droplets  of  universal 
IVF  medium,  in  which  they  were  cultured 
individually. 
 
The  OCCs  that  were  assigned  to  IVF  kept 
their  surrounding  cumulus  cells,  and  they 
were cultured individually in 25-μL droplets 
of universal IVF medium. Each oocyte was 
inseminated  with  75,000–150,000  motile 
spermatozoa  (standard  number  is  75,000), 
2–4  hours  after  oocyte  retrieval,  in  a  total 
volume of 25–30 μL. 
 
Assessment of Fertilization and cleavage: 
Sixteen  to  18  hours  later,  the  oocytes  were 
inspected  for  normal,  two-pronuclear 
fertilization.  The  rate  of  fertilization  was 
calculated  per  OCC.  Cleavage  and  embryo 
quality  was  evaluated  at  days  2  and  3  after 
oocyte  retrieval.  Embryos  were  assessed  for 
their  morphology  and  number  of  cells.  Rapid-
cleavage  embryos  were  defined  as  embryos 
sized  at  least  four  cells  at  2  days  after 
insemination  and  sized  at  least  six  cells  at  3 
days after insemination.  
 
Embryo Transfer and Pregnancy Testing:  
Embryo transfer took place 3 days after oocyte 
retrieval  under  ultrasonic  guide.  The  highest 
quality  embryos  were  transferred  regardless  of 
their method of insemination. Depending on the 
woman’s  age  and  the  embryo  quality,  two  to 
three  embryos  were  transferred.  Good-quality 
excess embryos were cryopreserved.  
 
On the 14
th days of the transfer, a serum β-hCG 
test  was  performed  to  confirm  pregnancy. 
Pregnancy was defined by an increasing β-hCG 
of  ≥50  IU/L  at  14  days  after  oocyte  retrieval. 
Ongoing pregnancy was defined by the presence 
of a gestational sac with fetal heartbeat after 12 
weeks of gestation. 
 
Data registration and Statistical analysis:  
The  results  were  tabulated  and  statistically 
analyzed  using  a  computer  program  SPSS 
(statistic a  package  for  social  science),  version 
15.  The  sample  mean  (X),  standard  deviation 
(SD), and standard error of the mean as well as 
the range were obtained for numerical variables. 
For  non-numerical  variables,  the  frequency, 
distribution and percentage were calculated. The 
student's (t) test was used to test the significance 
of the difference between 2 independent means. 
The  Chi  square  test  (X²)  was  used  to  test 
whether  the  distribution  of  a  certain 
phenomenon  among  two  or  more  groups  was 
equal or not.  
 
 
Results 
 
Two hundred and five patients undergoing IVF 
and  eligible  for  our  criteria  were  started  the 
treatment in this study. Four patients with very 
poor response (less than 2 growing follicles on 
cycle day 14) and three patients with less than 4 
retrieved  oocytes  were  excluded.  On  the  other 
hand, three patients were refused to participate 
and  five  patients  were  not  meeting  inclusion 
criteria.  One  hundred  and  ninety  patients  were 
randomized  to  undergo  an  IVF  cycle  in  which 
oocytes were divided without prejudice between 
conventional  IVF  and  ICSI.  The  flowchart  of 
the  patients  included  in  the  study  is  shown  in 
figure 1. 
   Ashraf Moawad….et al 
 
125 
  
 
 
 
Figure 1: Flowchart of the patients included in this study. 
 
Table 1: Collective data of oocytes inseminated by conventional IVF and ICSI in 190 patients 
with mild male factor infertility 
 
  Oocytes  retrieved 
(n=1662) 
Oocytes by ICSI 
(n=833) 
Oocytes by IVF 
(n=829) 
Patients  with  fertilization  by 
IVF and ICSI (n= 145) 
 
1282 
 
642 (50.1%) 
 
640 (49.9%) 
Patients  with  fertilization  only 
by ICSI (n= 41) 
 
351  
 
176 (50.1%) 
 
175 (49.9%) 
Patients  without  fertilization 
by ICSI and IVF (n= 4) 
 
29  
 
15 (51.7%) 
 
14 (48.3%) 
 
In 190 oocyte retrievals, 1,662 oocytes were collected and divided randomly without  prejudice 
between  conventional  IVF  and  ICSI  procedures.  833  oocytes  were  allocated  to  the  ICSI 
procedure (746 of them were microinjected) and 829 oocytes were assigned to the conventional 
IVF procedure  
 
77.2% of retrieved oocytes (1282/1662) were fertilized by both IVF and ICSI, 21.1% of retrieved 
oocytes (351/1662) were fertilized only by ICSI and 1.7% of retrieved oocytes (29/1662) were 
not  fertilized  either  by  IVF  or  ICSI. 
Allocated to 
insemination by IVF 
(829 COC) 
 
Assessment of 
Eligibility 
N=205 
Randomization 
N=190 
Allocated to 
insemination by ICSI 
(833 COC) 
 
Excluded (n=8) 
  Refused to participate 
(n=3). 
  Not meeting inclusion 
criteria (n=5). 
 
Analyzed  
(833 COC) 
Analyzed 
(829 COC) 
 
Excluded (n=7) 
  Cancellation  of 
OPU (n=4). 
  <4  retrieved  oocyte 
(n=3). 
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On the other hand, 76.3% of patients (145/190) were fertilized by both IVF and ICSI, 21.6% of 
patients (41/190) were fertilized only by ICSI while 2.1% of patients (4/190) were not fertilized 
either by IVF or ICSI. These data are provided in Table 1. 
 
 
Table 2: Sperm parameters of the 190 patients included in this study 
 
  Concentration  
(X 10
6 ml) 
Motility  percentage 
(%) 
Total  motile  count 
(X 10
6) 
Patients with fertilization by 
IVF and ICSI (n=145) 
      -     Before Processing 
      -     After Processing 
 
 
24.2 ± 21.7 
31.6 ± 25.4 
 
 
42.5 ± 22.6 
59.7 ± 29.4 (c) 
 
 
28.5 ± 24.9 (a) 
8.6 ± 4.8 
Patients  with  fertilization 
only by ICSI (n=41) 
-  Before Processing 
-  After Processing 
 
 
18.8 ± 13.4 
25.7 ± 19.2 
 
 
36.5 ± 19.3 
43.4 ± 22.6 (d) 
 
 
20.4 ± 15.7 (b) 
6.7 ± 5.2 
Patients  without  fertilization 
by ICSI and IVF (n=4) 
-  Before Processing 
-  After Processing 
 
 
 
16.4 ± 11.6 
21.5 ± 13.8 
 
 
 
30.1 ± 9.4 
39.6 ± 12.9 
 
 
 
7.3 ± 3.9 
4.9 ± 3.6 
 
a,b: Significantly different from each other (P< 0.05) 
c,d: Significantly different from each other (P< 0.01) 
 
 
Sperm parameters before and after preparation in all patients are shown in Table 1. Significant 
differences  were  found  in  patients  with  fertilization  by  both  IVF  and  ICSI  compared  with 
fertilization only by ICSI with regard to motility after preparation (59.7 ± 29.4 % vs. 43.4 ± 22.6 
%; P < 0.05) and the mean total motile sperm count before preparation (28.5 ± 24.9 x 10
6 vs. 20.4 
± 15.7 × 10
6, P < 0.01). For the four patients with no fertilization in both the IVF-treated and the 
ICSI-treated  oocytes,  the  sperm  parameters  were  not  significantly  different  from  those  of  the 
other two groups. 
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Table 3: Outcome after conventional IVF and ICSI performed on sibling oocytes in 190 patients 
with mild male factor infertility 
 
  Fertilization  Type 1-2 Embryos 
ICSI fertilized 
(n=531) 
IVF fertilized 
(n=367) 
ICSI embryos 
(n=(403) 
IVF embryos 
(n=207) 
   
(63.7%)
a 
 
(44.3%)
b 
403/531 
(75.9%)
c 
207/367 
(56.4%)
d 
Patients  with  fertilization 
by IVF and ICSI (n= 145) 
 
423/642 
(65.9%) 
 
367/640 (57.3%) 
 
327/423 
(77.3%)
e 
 
207/367 
(56.4%)
f 
Patients  with  fertilization 
only by ICSI (n= 41) 
 
108/176 
(61.4%) 
 
0/175 
(0%) 
 
76/108 (70.4%) 
 
 
NA 
Patients  without 
fertilization  by  ICSI  and 
IVF (n= 4) 
 
0/15 
(0%) 
 
0/14 
(0%) 
 
 
NA 
 
 
NA 
 
a,b Significantly different from each other (P<.05). 
c,d Significantly different from each other (P<.05). 
e,f Significantly different from each other (P<.01). 
NA = not applicable. 
 
Among 145 of the 190 treated couples, fertilization occurred both after ICSI (423/642 oocytes; 
65.9%)  and  after  IVF  (36 7/640  oocytes;  57.3%),  whereas  among  41  of  the  190  couples, 
fertilization was observed only after ICSI (108/176 oocytes; 61.4%) and not after IVF. In four 
couples, there was no fertilization after ICSI (0/15 oocytes) and IVF (0/14 oocytes). All these 
patients had mature oocytes and no morphological abnormalities of the oocytes were observed. 
 
In the current study, fertilization rate was significantly higher in oocytes injected by ICSI (63.7%) 
compared to oocyte inseminated by IVF (44.3%). In patients fertil ized by both IVF and ICSI, 
although ICSI fertilization rate was higher (65.9%) than IVF fertilization rate (57.3%), yet there 
is no significant differences were observed. These data are provided in Table 2. 
 
High grade embryos were significantly higher in oocytes injected by ICSI (75.9%) compared to 
oocyte inseminated by IVF (56.4%). Also,  significantly more type 1 and 2 embryos developed 
after ICSI compared with IVF (77.3% vs. 56.4%) in the group of patients with fertilization after 
both IVF and ICSI. There was no difference in embryo quality between ICSI embryos developed 
in cycles with and without fertilization in IVF (77.3% vs. 70.4%). These results also  are given in 
Table 3. 
 
Table 4: Embryo transfer, pregnancy rate, and implantation rate (178 patients). 
 
  Patients with fertilization by IVF and ICSI 
(n = 139)
a  
Patients with fertilization 
only by ICSI (n = 39)
b 
  IVF  IVF+ICSI  ICSI  ICSI   IVF 
Transfers  32 (23.0%)  46 (33.1%)  61 (43.9%)  39  0 
Pregnancies  12 (37.5%)  20 (43.5%)  28 (45.9%)  18 (46.2%)  0 
Ongoing pregnancies  11 (34.4%)  19 (41.3%)  26 (42.6%)  16 (41.0%)  0 Split ICSI/Insemination…. 
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a  
In 6 patients, there was no transfer because of ovarian hyperstimulation syndrome  and unsuitable 
embryos for transfer. 
b 
In 2 patients there was no transfer because of ovarian hyperstimulation syndrome . 
In 12 of the 190 patients there was no transfer; in 5 patients, because of ovarian hyperstimulation 
syndrome, in 4 patients because of fertilization failure and in 3 patients, because there was no 
suitable embryos.  
 
Overall, more ICSI embryos were transferred compared with the case of IVF embryos (335 vs. 
163).  
 
In patients with fertilization by IVF and ICSI (n = 139), 226 ICSI embryos and 163 IVF embryos 
were transferred: 32 transfers of only IVF embryos (23.0%), 46 transfers of a mixture of IVF and 
ICSI embryos (33.1%), and 61 transfers of only ICSI embryos (43.9%). 
 
In total, 78 patients became pregnant: 60 in the group with fertilization after both IVF and ICSI 
(42.3% per transfer) and 18 in the group with fertilization only after ICSI (46.2% per transfer) 
and).  No  significant  differences  were  found  with  regard  to  pregnancy  rates  and  ongoing 
pregnancies between the three groups of embryo transfers (IVF, IVF-ICSI, and ICSI). These data 
are given in Table 4. 
 
Discussion 
 
Reports  of  higher  fertilization  rates  after 
ICSI suggesting that  this technique may  be 
better  than  conventional  methods  for  all 
couples seeking IVF have led to controversy 
for  a  long  time.  However,  among  other 
concerns,  current  knowledge  of  ICSI  as  an 
outcome  procedure  does  not  provide  the 
confidence to use this process in all cases of 
IVF for the time being, even if ICSI offers a 
higher  incidence  of  fertilization,  maximizes 
the  number  of  embryos,  and  minimizes  the 
risk  of  complete  failure  of  fertilization 
(Fishel S 2000 & Van Rumste MM 2004).  
 
Comparing  the  clinical  outcomes  obtained 
from IVF vs. ICSI is difficult because each 
treatment  deals  with  different  infertility 
indications. Reports regarding the outcomes 
of  IVF  vs.  ICSI  are  controversial  and 
complicated  by  different  inclusion  criteria 
for  ICSI.  Hsu  et al.  (1999)  reported  that 
IVF-derived  day-3  embryos  had  better 
cleavage  rates  and  morphology  scores  than 
did  ICSI-derived  day-3  embryos  in 
consecutive  couples  undergoing  ART 
therapy.  Dumoulin  et al.  (2000) 
demonstrated  that  embryos  obtained  after 
ICSI  had  a  decreased  potential  to  develop 
into blastocysts. Chang et al. (2000), Lan et 
al  (2001)  and  Yoeli  et al  (2008)  also 
revealed that embryo quality does not seem 
to be influenced by the mode of fertilization 
(IVF or ICSI). Yu-Che et al (2010) assumed 
that  embryo  quality  depends  on  intrinsic 
factors of the gametes involved, rather than 
on the fertilization process per se.  
 
In  patients  with  borderline  semen,  the 
decision  to  choose  either  conventional  IVF 
or ICSI is critical because the chance of total 
fertilization failure after a conventional IVF 
or  of  performing  an  unnecessary  ICSI 
procedure is hard to predict. The question is 
how  to  discriminate  between  patients  who 
do and do not need ICSI to fertilize. In the 
literature, there is no answer to this question.  
Van der Westerlaken et al (2006) concluded 
that  in  patients  with  subfertile  semen,  the 
treatment  of  sibling  oocytes  with  both  IVF 
and ICSI remains the optimal tool to prevent 
total  fertilization  failure  after  conventional 
IVF 
Plachot et al (2002) in their study confirms 
that performing conventional IVF and  ICSI
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in  sibling  oocytes  in  the  first  cycle  for 
couples  with  borderline
  semen  quality 
decreases  the  risk  of  transfer  cancellation 
over
  that  for  conventional  IVF  alone.  In 
addition, it is also an excellent test
 of sperm 
fertilizing ability, to be used as a  guideline 
for
  the  management  of  possible  future 
cycles. 
Similar studies comparing IVF and ICSI in 
sibling oocytes from
 couples with borderline 
semen  quality  have  been  reported 
(PisarskaMD  1999,  VerheyenG  1999, 
Aboulghar1996,  Plachot  M2002,  Calderon 
G1995  &  Van  der  Westerlken2006).  All 
concluded  that  this  practice  prevented  the 
cancellation
  of  embryo  transfer  due  to 
complete  fertilization  failure  after
 
conventional IVF (which  occurs in  25-50% 
of  the  cycles)  and  the  cycles  with 
fertilization  after  both  IVF  and  ICSI  show 
similar  fertilization  rates  of  the  IVF-  and 
ICSI-treated  oocytes.  Indeed,  the  overall 
fertilization rate was
 higher after ICSI (50–
63% depending on the study) than
 after IVF 
(18–23%).  
In  case  of  male  subfertility,  the  ICSI 
treatment  results  in  significant  higher 
fertilization  rate  per  oocyte  compared  with 
conventional  IVF  treatment  in  this  study 
(63.7%  vs.  44.3%).  However,  when  the 
fertilization  percentage  is  calculated  per 
patient,  three  groups  of  patients  can  be 
discriminated:  one  with  fertilization  after 
both  conventional  IVF  and  ICSI,  one  with 
fertilization only after ICSI, and one without 
fertilization after either conventional IVF or 
ICSI.  In  the  first  group,  although  ICSI 
fertilization  rate  was  higher  (65.9%)  than 
IVF fertilization rate (57.3%), yet there is no 
significant differences were observed. 
 
These results are in agreement with Michael 
et al (2003), Shai et al (2004), Hackett et al 
(2005), Gvakharia et al (2005), and Van der 
Westerlaken et al (2006).  
 
Michael  et  al  (2003)  in  their  retrospective 
study  to  assess  the  value  of  split 
ICSI/Insemination  in  mild  male  factor 
infertility or in case of complete fertilization 
failure  with  normal  semen  parameters, 
concludes that the routine use of this method 
will  maximize  fertilization  rates  and  the 
yield of good-quality embryos. 
 
Shai  et  al  (2004)  suggested  that,  in  their 
retrospective  study,  implementation  of  split 
ICSI  in  couples  with  mild  male  factor 
infertility  could  improve  fertilization  rates 
and  decrease  the  risk  of  complete 
fertilization  failure  but  possibly  may  be 
associated  with  a  lower  number  of  early 
cleaving  embryos.  On  the  other  hand,  they 
did not encourage performing this procedure 
in  infertile  couples  with  normal  sperm 
characteristics. 
 
Hackett  et  al  (2005)  in  their  retrospective 
analysis  to  determine  the  effect  of 
insemination  method  on  embryo 
development  within  a  cohort  of  eggs,  they 
found that  the fertilization rate, determined 
by  the  number  of  2  pronuclear  zygotes  on 
day1  divided  by  the  number  of  eggs 
inseminated, was  
significantly  different  (ICSI  68%;  IVF 
47%).  Significance  was  lost  however  when 
the fertilization rate for the ICSI group was 
calculated  by  the  total  number  of  eggs 
available  rather  than  by  those  that  were 
mature  (ICSI  53%;  IVF  47%).  The 
occurrence  of  failed  fertilization  was 
significantly  different  in  the  two  groups 
(ICSI 2.5%; IVF 19.2% p<0.0001). Finally, 
they suggest that in patient with infertility of 
unknown etiology a split IVF/ICSI cycle can 
help reduce failed fertilization.  
 
Gvakharia et al (2005) in their retrospective 
study  to  analyze  laboratory  and  clinical 
outcome  indicators  of  split 
ICSI/Insemination  in  mild  male  factor 
concludes  that  Split  ICSI  is  a  reasonable 
option  for  patients  with  sub-optimal  sperm 
parameters and also for patients who wish to 
minimize  the  risk  of  fertilization  failure  in 
IVF.  In  10%  of  patients,  the  split  ICSI 
procedure  avoided  total  failure  of 
fertilization  and  supplied  embryos  for 
transfer. Split ICSI/Insemination…. 
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Van  der  Westerlaken  et  al  (2006)  in  their 
randomized study, they found in the patients 
fertilized  after  both  conventional  IVF  and 
ICSI, the  fertilization percentages  are  same 
and  they  suggest  an  all-or-nothing  effect 
with  regard  to  the  fertilization  capacity  in 
conventional IVF. Patients with fertilization 
after  conventional  IVF  apparently  do  not 
need  to  be  treated  with  ICSI  and  once 
fertilization has been established, there is no 
difference  in  developmental  competence 
between IVF and ICSI treatment. 
 
In  contrast  to  our  finding,  Hershlag  et  al 
(2002)  found  no  improvement  in 
fertilization  rates  after  ICSI  in  cases  with 
borderline  semen  characteristics.  In  their 
study,  however,  borderline  sperm  was 
defined  as  sperm  with  20%–30%  motility, 
which is nearly the same as the definition we 
used  in  our  study:  motility  of  25%–40%. 
However, they did not pay attention to other 
sperm parameters as count and morphology 
which  may  partly  explain  the  difference  in 
our findings. 
 
With  regard  to  embryo  quality,  we  found 
significantly  higher  quality  embryos  after 
ICSI compared with IVF (75.9% vs 56.4%). 
Also,  we  found  significantly  higher  quality 
embryos after ICSI (77.3%) compared with 
IVF  (56.4%)  in  patients  who  became 
fertilized both after IVF and after ICSI. This 
difference  did  not  reach  significance  when 
ICSI  embryos  from  patients  who  became 
fertilized  only  after  ICSI  (70.4%)  were 
compared  with  the  IVF-fertilized  embryos 
(77.3%). 
 
 
This  is  in  agreement  with  Michael  et  al 
(2003) and van der Westerlaken et al (2006) 
but not in agreement with other studies that 
did  not  find  differences  in  embryo  quality 
between IVF and ICSI (Pisarska MD 1999, 
VerheyenG  1999,  Plachot  M2002  & 
Tournaye H2002).  
 
 
 
 
Whether  it  is  the  technique  (IVF  or  ICSI) 
that is responsible for this observation is not 
clear. Patient variation as well as differences 
in sperm characteristics can be excluded as a 
possible explanation because sibling oocytes 
and the same semen sample have been used 
to establish fertilization. It might be that the 
ICSI  embryos  develop  faster  than  the  IVF 
embryos.  This  is  a  known  phenomenon 
inherent  to  the  ICSI  technique  (Nagy 
Z1998). It might also be that exposure of the 
IVF  embryos  to  large  numbers  of 
spermatozoa,  creating  suboptimal  culture 
conditions,  affects  embryo  quality 
negatively.  This  negative  effect  might  be 
avoided  by  using  the  short  insemination 
method  in  conventional  IVF  (Quinn  P1998 
& Menezo Y2000). The fact that more ICSI 
embryos  are  transferred  than  IVF  embryos 
(table4)  can  be  explained  by  the  fact  that 
there are more ICSI embryos available and 
that  the  ICSI  embryos  are  of  a  higher 
quality.  
 
The  embryos  in  the  current  study  were 
transferred  based  on  embryo  quality 
regardless  of  their  origin  from  ICSI  or 
conventional  IVF.  So  the  IVF  and  ICSI 
embryos  that  were  transferred  were  of 
similar  quality.  This  explains  the  similar 
(ongoing) pregnancy rates between IVF and 
ICSI treatment (table 4). 
 
In  conclusion,  according  to  our  findings, 
implementation of ICSI in couples with mild 
male  factor  infertility  could  improve 
fertilization  rates  and  decrease  the  risk  of 
complete  fertilization  failure.  Additionally, 
split  ICSI  procedure  provides  valuable 
clinical  information  about  fertilization 
potential for the couple and unnecessary use 
of ICSI procedure can be avoided in future 
cycles for patients who have achieved good 
fertilization in both IVF and ICSI. 
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 ثااضيىب لخاد اهل يرهجملا نقحلا نيب اهتردن تلاح ًف ميقعلا جوزلا نم تيىنملا ثاناىيحلا ميسقت
لمعملا ًف تيىنملا ثاناىيحلا عم ثاضيىبلا تناضح نيبو تجوزلا  . ةددحم تيئاىشع تبرجت  
 
  رهاظلا دبع دمحم    تيرىبا ءانه    ضىعم فرشأ       محم    ثاحرف دمحم ى ريعش د  
 ةطها حيوك –  شٓصلاا حؼًاخ –   جشٓاقها  
 حيوخها زاحتا ضكشًٕ ةطها حيوك – خاساًلاا  
يقؼوه بادُا ٘فشرسً -   خاساًلاا  
 
  تمدقملاا :    ةييصخره جذػاسً حويسٕ حخٕضها خاعيٖت نخاد ييقؼها جٕضها ًَ حيٌِٖها خاُاٖيحوه ٗشٔدٌها َقحها شثرؼي
اييؼ ٖرً بايصخلاا نييشص ٍٖيلي اييٌِيي ييشيها جساييخ خايعيٖثها  . ٘ييظشٌها ٘يص    جدٕذييحٌها بايصخلاا جسذيي  ٕٗر سٖكزيها
 غييً خاييعيٖثها حُاييعي َيييتٕ حييخٕضها خاييعيٖت نييخاد حيييٌِٖها خاييُاٖيحوه ٗشيئدٌها َييقحها َيييت ساشييقها راييخذا شييثرؼي
 جسايخ خايعيٖثوه ٗذييوقرها ةييصخرها ذيؼت نيشفوه حيولها حصشفها غ ٖذ ةؼصي ُْلا اخشي نٌؼٌها ٘ص حيٌِٖها خاُاٖيحها
ٗشٔدً َقي نٌػ ٕا ييشها   خاعيٖثها نخاد حيٌِٖها خاُاٖيحوه .  
تساردلا نم فدهلا :    أيعؼتٕ ٗشئدٌها َيقحوه خايعيٖثها طؼت صيصخذ حيٌٓا  يييقذ ٖٓ حساسذها ّزٓ ًَ ضشغها
ٌِٖٗها نئاسوه حيثيصخرها جسذقها فؼظ خاششؤً دٖخٕ ذِػ ييشها جساخ ٗذيوقرها ةيصخروه  .  
تساردلا ميمصت :   حيوثقرسً حساسد ّزٓ .  
طلاو داىملا قر :    عاعخا يذ 091    سطسغا ًَ جشرفها ٘ص حعيشً 7112    نيشتا ٘ها 7101    ةييصخذ ييذ سييي حساسذوه
 ٗذييوقرها ةييصخرهات شيخ ا فيصِهإ ٗشئدٌها َيقحها ىاذخرسات خاعيٖثها فصُ (  خايُاٖيحها غيً خايعيٖثها حُايعي
نٌؼٌها ٘ص حيٌِٖها   .)  
جئاتنلا :    ةييصخذ ييذ حيساسذها ّزيٓ ٘يص 2..7  %  غيً خايعيٖثها حُايعي ٕ ٗشئدٌها َيقحها ىاذخريستت خايعيشٌها َيً
نييٌؼٌها ٘ييص حيييٌِٖها خاييُاٖيحها  , 70..  %  ييقص ٗشيئدٌها َييقحها ىاذخرييستت َٔثيييصخذ يييذ خاييعيشٌها َييً  ,  يرييي يييه اييٌِيت
 ةيصخذ 7.0  % اؼً َيرقيشطها ىاذخرستت  . ٘يص  ظٖحوً نلشت ٘وػا ٍاك ةيصخرها مذؼً    َِٔيقي ييذ  ٘يذتها خايعيٖثها
 ايشٔدً ( .7.2 )%  ,  نٌؼٌها ٘ص حُاعي ٘ص حيٌِٖها خاُاٖيحها غً َٔؼٌخ يذ ٘ذتها خاعيٖثهات حُساقٌهات  
...7  .)%  ٘ص حيٌِٖها خاُاٖيحها غً خاعيٖثها حُاعيٕ ٗشٔدٌها َقحها ىاذخرستت  اؼً َثصخ ٘ذتها خاعيشٌها ٘ص
ةيصخرها مذؼً ٍا ًَ يغشها ٘وػٕ نٌؼٌها    ٗشئدٌها َيقحها ىاذخريستت َثيصخ ٘يذ ها ٘يص ٘يوػا ٍايك ( ...9  )%  َيػ
 نييٌؼٌها ٘ييص حيييٌِٖها خاييُاٖيحها غييً خاييعيٖثها حُاييعي ىاذخرييستت َثييصخ ٘ييذتها ( .2.7 )%  ,  حيييٌٓا ذييخٖذلا ْييُا لاا
كهر ٘وػ حيئاصيا  .  ايشٔدً دِقي ٘ذتها خاعيٖثها ًَ جدٖدها حيهاػ حِخا ظٖحوً نلشت ددرُٕ ( 2..9  )% حيُساقٌهات  
نٌؼٌها ٘ص حيٌِٖها خاُاٖيحها غً حِعحٌها خاعيٖثها ًَ ددرُ ٘ذتها حِخلأات  .  حيِخا خسٖيطذ ظٖيحوً نلشتٕ اعيإ
 حُساقٌهات ٗشٔدٌها َقحها ذؼت ُ٘اثهإ مٕلاا عِٖها ًَ شثكا  
 
 
 نٌؼٌها ٘ص حيٌِٖها خاُاٖيحها غً حِعحٌها خاعيٖثها ًَ ددرُ ٘رهات ( 22.7  %  نتاقً ....  .)%  
جاتنتسلإا :    َيً ٍُٖايؼي َيزيها جإص يه حيعيٖثها نيخاد ٖٗيٌِها ٍاٖييحوه ٗشٔدٌها َقحها قيثطذ ٍتص حئارِها ٘ها شظِهات
اييًاٌذ باييصخلأا نييشص شييطخ َييً نييوقي اييٌك باييصخلأا مذييؼً َييً َييسحي ٍا َييلٌي باييصخيا ٘ييوػ جدٕذييحً جسذيي   .
ُايعي َييتٕ ٗشئدٌها َيقحها َييت حييٌِٖها خايُاٖيحها يييسقذ ٍتيص كيهر ٘يها حصاظلأاتٕ  ىذيقي نيٌؼٌها ٘يص حيعيٖثها غيً حر
 ٘يص ٗشئدٌها َيقحوه ٗسٕشظ شيغها ىاذخرسلأا ةِدذ َلٌيٕ باصخلأا خلااٌريا َػ َيخٕضوه حًآ حيٌوػ خاًٖوؼً
 خايُاٖيحها غيً خايعيٖثها حُايعيٕ ٗشئدٌها َيقحها ىاذخريستت ذييخ بايصخا ٘وػ َوصي ٘ذتها خاعيشٌوه نثقرسٌها
اؼً نٌؼٌها ٘ص حيٌِٖها  .  
 
 
 